SM
BIOR

Sabby Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Sabby Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$158K – 136
2022
Q3 		$158K Hold
13
– – 0.2% 65
2022
Q2 		$221K Sell
13
-8
-38% -$1.69K 0.15% 68
2022
Q1 		$599K Sell
21
-10
-32% -$3.79K 0.09% 58
2021
Q4 		$1.61M Buy
31
+11
+55% +$7.89K 0.23% 59
2021
Q3 		$772K Buy
+20
New +$8.58K 0.1% 101

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Sabby Management's BIOR Position: Q4 2023 in Review

Sabby Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2023, closing a stake of 37,656 shares — an estimated $817K sold.

Sabby Management first reported a position in BIOR in Q4 2021 and held it in 7 quarters. The position peaked at $2.27M in Q4 2021. 29 funds tracked by Wall St. Rank hold BIOR as of Q4 2023.

  • Sabby Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Sabby Management sold 37,656 Biora Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $817K.
  • Sabby Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Sabby Management's Biora Therapeutics, Inc. Common Stock position peaked at $2.27M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.